Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Deferred Taxes (2021 - 2023)

Firefly Neuroscience has reported Deferred Taxes over the past 3 years, most recently at -$42934.0 for Q4 2023.

  • Quarterly results put Deferred Taxes at -$42934.0 for Q4 2023, up 98.87% from a year ago — trailing twelve months through Dec 2023 was -$42934.0 (up 98.58% YoY), and the annual figure for FY2023 was -$42934.0, up 98.58%.
  • Deferred Taxes for Q4 2023 was -$42934.0 at Firefly Neuroscience, up from -$3.8 million in the prior quarter.
  • Over the last five years, Deferred Taxes for AIFF hit a ceiling of $463573.0 in Q1 2022 and a floor of -$3.8 million in Q4 2022.
  • Median Deferred Taxes over the past 3 years was -$17125.0 (2022), compared with a mean of -$688818.7.
  • Biggest five-year swings in Deferred Taxes: plummeted 254.33% in 2022 and later soared 98.87% in 2023.
  • Firefly Neuroscience's Deferred Taxes stood at -$1.1 million in 2021, then plummeted by 254.33% to -$3.8 million in 2022, then soared by 98.87% to -$42934.0 in 2023.
  • The last three reported values for Deferred Taxes were -$42934.0 (Q4 2023), -$3.8 million (Q4 2022), and $8684.0 (Q3 2022) per Business Quant data.